BDTX
Price
$2.48
Change
+$0.13 (+5.53%)
Updated
Jun 30 closing price
Capitalization
141.02M
42 days until earnings call
INMB
Price
$2.31
Change
-$3.02 (-56.66%)
Updated
Jun 30 closing price
Capitalization
53.31M
29 days until earnings call
Interact to see
Advertisement

BDTX vs INMB

Header iconBDTX vs INMB Comparison
Open Charts BDTX vs INMBBanner chart's image
Black Diamond Therapeutics
Price$2.48
Change+$0.13 (+5.53%)
Volume$1.31M
Capitalization141.02M
INmune Bio
Price$2.31
Change-$3.02 (-56.66%)
Volume$32.95M
Capitalization53.31M
BDTX vs INMB Comparison Chart in %
Loading...
BDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INMB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BDTX vs. INMB commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDTX is a Hold and INMB is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 01, 2025
Stock price -- (BDTX: $2.48 vs. INMB: $2.31)
Brand notoriety: BDTX and INMB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BDTX: 104% vs. INMB: 1217%
Market capitalization -- BDTX: $141.02M vs. INMB: $53.31M
BDTX [@Biotechnology] is valued at $141.02M. INMB’s [@Biotechnology] market capitalization is $53.31M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BDTX’s FA Score shows that 1 FA rating(s) are green whileINMB’s FA Score has 0 green FA rating(s).

  • BDTX’s FA Score: 1 green, 4 red.
  • INMB’s FA Score: 0 green, 5 red.
According to our system of comparison, BDTX is a better buy in the long-term than INMB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BDTX’s TA Score shows that 4 TA indicator(s) are bullish while INMB’s TA Score has 5 bullish TA indicator(s).

  • BDTX’s TA Score: 4 bullish, 4 bearish.
  • INMB’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both BDTX and INMB are a good buy in the short-term.

Price Growth

BDTX (@Biotechnology) experienced а +9.25% price change this week, while INMB (@Biotechnology) price change was -62.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.71%. For the same industry, the average monthly price growth was +31.92%, and the average quarterly price growth was +6.10%.

Reported Earning Dates

BDTX is expected to report earnings on Aug 12, 2025.

INMB is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+3.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BDTX($141M) has a higher market cap than INMB($53.3M). BDTX YTD gains are higher at: 15.888 vs. INMB (-50.535). BDTX has higher annual earnings (EBITDA): -3.66M vs. INMB (-41.52M). BDTX has more cash in the bank: 152M vs. INMB (19.3M). INMB has less debt than BDTX: INMB (347K) vs BDTX (21.6M). BDTX has higher revenues than INMB: BDTX (70M) vs INMB (50K).
BDTXINMBBDTX / INMB
Capitalization141M53.3M265%
EBITDA-3.66M-41.52M9%
Gain YTD15.888-50.535-31%
P/E Ratio41.33N/A-
Revenue70M50K140,000%
Total Cash152M19.3M788%
Total Debt21.6M347K6,225%
FUNDAMENTALS RATINGS
INMB: Fundamental Ratings
INMB
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BDTXINMB
RSI
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
87%
MACD
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 7 days ago
80%
Bullish Trend 7 days ago
83%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 1 day ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
BDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INMB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CNPIX75.75N/A
N/A
Consumer Staples UltraSector ProFund Inv
WFIOX56.46N/A
N/A
Allspring Index Admin
HQIVX21.29N/A
N/A
Hartford Equity Income R6
GIDUX7.97N/A
N/A
Goldman Sachs Intl Eq Div & Prem R6
SMYSX26.43N/A
N/A
Franklin Global Equity IS

INMB and

Correlation & Price change

A.I.dvisor indicates that over the last year, INMB has been loosely correlated with UBX. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if INMB jumps, then UBX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INMB
1D Price
Change %
INMB100%
-56.66%
UBX - INMB
55%
Loosely correlated
-50.21%
ABCL - INMB
47%
Loosely correlated
-4.99%
BDTX - INMB
42%
Loosely correlated
+5.53%
BEAM - INMB
38%
Loosely correlated
+1.25%
ORMP - INMB
38%
Loosely correlated
+4.65%
More